ClinMax™ Human Soluble Siglec-2 / CD22 ELISA Kit, PRO
![1.jpg 1.jpg](/SupplyImg1/2024-06-21/6385456360104200798806032.jpg)
背景(Background)
ClinMax™ ELISA Kit is convenient ready-to-use immunoassay Kit, specifically designed to quantitate human Siglec-2/CD22 that is present in complex biological samples, such as human serum, plasma, and cell culture supernates.
A comprehensive validation of the ELISA method was performed following the ICH M10 on bioanalytical method validation and the FDA’s bioanalytical method validation guidance for industry. This validation included assessments of linearity, accuracy, precision, dilution linearity, recovery, and the hook effect. For details information, please refer to the DS.
ClinMax™ ELISA Kits are manufactured in a GMP-like facility and comply to the ISO 13485 standard, ensuring a high level of quality and reliability.
原理(Assay Principles)
![2.jpg 2.jpg](/SupplyImg1/2024-06-21/6385456361039083023926810.jpg)
应用说明(Application)
The kit is developed for quantitative detection of human soluble Siglec-2/CD22 in serum, plasma and cell culture supernates.
It is for research use only.
存储(Storage)
Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
![3.jpg 3.jpg](/SupplyImg1/2024-06-21/6385456362013294157105489.jpg)
![4.jpg 4.jpg](/SupplyImg1/2024-06-21/6385456362539160944368180.jpg)
背景(Background):Siglec-2
CD22, or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins. It is found on the surface of mature B cells and to a lesser extent on some immature B cells. Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases.
关键字: Siglec-2 ELISA Kit;CD22试剂盒;Siglec-2 ELISA试剂盒;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。